Vallon Pharmaceuticals Inc (VLON)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -1349.922 | -140.956 | -184.362 | -200.28 | -112.501 | -366.826 |
| Return on Equity (%) | -5637.908 | -205.762 | -547.955 | -426.352 | -172.157 | -1002.461 |
| Return on Invested Capital (%) | -5639.216 | -193.023 | -611.494 | -447.836 | -172.639 | -875.586 |
| Operating Margin (%) | N/A | N/A | -4788 | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | -4822 | N/A | N/A | N/A |
| Book Value Per Share | 0.001 | 0.018 | -0.323 | 0.854 | 0.174 | 0.08 |
| Earnings Per Share | -0.038 | -0.019 | -1.07 | -1.365 | -0.521 | -4.016 |
| Cash Per Share | 0.005 | 0.021 | 0.024 | 0.543 | 0.28 | 0.557 |
| Working Capital Per Share | 0.001 | 0.017 | -0.344 | 0.834 | 0.174 | 0.073 |
| Operating Profit Per Share | N/A | N/A | 0.022 | N/A | N/A | N/A |
| EBIT Per Share | -0.038 | -0.019 | -1.07 | -1.365 | -0.521 | -4.016 |
| EBITDA Per Share | -0.038 | -0.019 | -1.07 | -1.365 | -0.521 | -4.016 |
| Free Cash Flow Per Share | -0.038 | -0.019 | -1.07 | -1.365 | -0.521 | -4.015 |
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 112.5M | 180.25M | 4.51M | 6.81M | 13.48M | N/A |
| Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
| Shares Outstanding | 13.48M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 1.3M |
| Price to Earnings Ratio | -0.1 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.72 |
| Price to Book Ratio | 5.01 |
| Dividend Yield | - |
| Shares Outstanding | 3.25M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
